Shares of Insmed jumped Tuesday after the biopharmaceutical firm reported positive results from a Phase 2 trial for its treatment of pulmonary arterial hypertension.

Pulmonary arterial hypertension (PAH) represents a complex disease with multifaceted pathophysiology involving over 20 identified genetic mutations that can contribute to disease development.

Panelists discuss how pulmonary arterial hypertension diagnosis requires comprehensive evaluation including right heart catheterization to confirm hemodynamic criteria, with normal mean PA ...

FDA’s approval of YUTREPIA paves the way for prescribers to add a new treatment option for patients with PAH and PH-ILDYUTREPIA is designed to enhance deep-lung delivery with an easy-to-use ...

An arterial blood gas test can find ways to help your lungs do their job. Find out when you get it and what the results mean.

Intra-arterial Lytics Don’t Help After Stroke Thrombectomy, but Questions Persist Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.

En los últimos dos años más o menos, muchos estadounidenses se encontraron de repente con hipertensión. Para unos 31 millones de ellos, no fue un aumento abrupto de la presión arterial lo que ...

SAN DIEGO — Increasing the mean arterial pressure target to 75 mmHg lowered the odds of 28-day mortality by 85%, and also reduced the odds of acute kidney injury nonrecovery, in decompensated ...

View pictures and learn how venous ulcers differ from arterial ulcers in their causes, symptoms, and treatment.

Clear shift in arterial diseases in diabetes Date: March 28, 2024 Source: University of Gothenburg Summary: There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes ...

The FDA has approved Winrevair (sotatercept-csrk) for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1).

With the FDA’s approval of Winrevair to treat pulmonary arterial hypertension, Merck is set to launch the first disease-modifying treatment for PAH.